Med School Research Scientist Timsy Uppal and Engineering post-doctoral researcher Bhaskar Vadlamani testing the SARS-CoV-2 nanosensor.
University of Nevada, Reno engineers and virologists team up for novel approach
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra’s lab at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra has used in the past for detecting tuberculosis and colorectal cancer as well as detection of biomarkers for food safety.
Professor Misra, in the University’s College of Engineering Chemical and Materials Department, has been working on nano-sensors for 10 years. He has expertise in detecting a specific biomarker in tuberculosis patients’ breath using a metal functionalized nano sensor.
“I thought that similar technology can be used to detect the SARS-CoV-2 virus, which is a folded protein,” Misra said. “This is Point of Care testing to assess the exposure to COVID-19. We do not need a laboratory setting or trained health care workers to administer the test. Electrochemical biosensors are advantageous for sensing purposes as they are sensitive, accurate and simple.”
The test does not require a blood sample, it is run using a nasal swab or even exhaled breath, which has biomarkers of COVID-19. Misra and his team have successfully demonstrated a simple, inexpensive, rapid and non-invasive diagnostic platform that has the potential to effectively detect the SARS-CoV-2 virus.
The team includes Associate Professor Subhash Verma, virologist, and Research Scientist Timsy Uppal at the University’s School of Medicine, and Misra’s post-doctoral researcher Bhaskar Vadlamani.
“Our role on this project is to provide viral material to be used for detection by the nanomaterial sensor developed by Mano,” Verma said. “Mano contacted me back in April or May and asked whether we can collaborate to develop a test to detect SARS-CoV-2 infection by analyzing patients’ breath. That’s where we came in, to provide biological material and started with providing the surface protein of the virus, which can be used for detecting the presence of the virus.”
Verma, an expert on SARS-CoV-2, synthesized and prepared the antigenic protein of COVID-19 virus in his laboratory, SARS-CoV-2 receptor binding domain protein, for the preliminary testing and determining the sensitivity of our nano sensor. Synthesizing and purification of viral proteins is usual and routine work in a virology laboratory.
“Our lab is a virology laboratory, which works on different viruses, and we have been working on SARS-CoV-2 from the beginning of the outbreak,” he said. “Our genomics and diagnostic group have been sequencing the SARS-CoV-2 from the nasal swabs of COVID-19 patients of the state of Nevada to determine mutational changes in the virus while SARS-CoV-2 circulates in our population.”
The team developed co-metal functionalized nanotubes as a sensing material for electrochemical detection of the protein. They confirmed the biosensor’s potential for clinical application by directly analyzing the RBD of the Spike glycoprotein on the sensor.
The team plans to move to the next step of sensor validation on the actual COVID-19 patients swabs stored in the Viral Transport Medium (VTM) and have applied for funding to develop a specific and inexpensive point-of-care sensor for a rapid detection of COVID-19 virus in saliva or breath of infected individuals.
“A rapid and accurate testing method is critical to establishing a rigorous testing protocol to allow us to continue our operations while maximizing the safety of our students, faculty and staff,” College of Engineering Dean Manos Maragakis said. “I am excited and proud that a research team led by faculty from the College of Engineering in collaboration with faculty from our Medical School are leading such a promising and innovative effort. I am looking forward to the outcome.”
The developed approach also has the potential for diagnosis of other respiratory viral diseases by identifying appropriate metallic elements to functionalize nanotubes.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Quixplained: Should you get tested for Covid-19 just to rule it out?on October 15, 2020 at 9:45 pm
No test for Covid-19 is 100 per cent accurate. Diagnostic tests, including the ones used for detection of the novel coronavirus, have a margin of error and often generate results that are false ...
- The importance of early breast cancer detectionon October 15, 2020 at 9:25 pm
With all the focus on the coronavirus pandemic it can be easy to forget that routine cancer screenings can save your life."Early ...
- COVID-19–Associated Multisystem Inflammatory Syndrome in Children — United States, March–July 2020on October 15, 2020 at 9:19 pm
This report highlights the clinical signs and symptoms of multisystem inflammatory syndrome in children, a rare but serious condition that can present 2-4 weeks after the onset of COVID-19.
- Nokia unveils thermal detection solution to fight Covid-19on October 15, 2020 at 1:54 pm
Leveraging advanced analytics, a business rules engine, centralised management, machine learning and ubiquitous connectivity, the Nokia so ...
- Leader in COVID-19 Prevention and Detection Upgrades Listing to NEO Exchangeon October 15, 2020 at 7:30 am
QuestCap Inc., a medical technology company currently focused on the prevention, detection, and treatment of COVID-19, graduates to NEO from the CSE.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test Systemon October 15, 2020 at 2:55 pm
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, ...
- Beckman Coulter bags BARDA funding for rapid detection of MIS-C, COVID-19 complication in childrenon October 15, 2020 at 6:40 am
Beckman Coulter is awarded funding by the Biomedical Advanced Research and Development Authority (BARDA), for a multi-center clinical trial to validate the ability of its Monocyte Distribution Width ...
- Paragon Genomics Expands Portfolio of CleanPlex® SARS-CoV-2-Related NGS Testson October 14, 2020 at 4:00 am
Paragon Genomics, Inc., a leader in amplicon-based target enrichment solutions for next-generation sequencing (NGS) and precision medicine, today announced the introduction of new coronavirus-related ...
- Salivary samples highly effective in detecting SARS-CoV-2on October 13, 2020 at 7:32 pm
A team of scientists from the United States has found that oral salivary samples are less sensitive than nasal-oropharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 ...
- Salimetrics Supports COVID-19 Research Efforts with Oral Fluid/Saliva-Based Antibody Assay for SARS-CoV-2 Surveillanceon October 13, 2020 at 1:15 am
Today, Salimetrics announces the release of their SARS-CoV-2 Nucleocapsid Protein (N-protein) specific IgG antibody kit ...